Andrea Bartuli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrea Bartuli has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Anna Alisi
Research Unit of Genetics of Complex Phenotypes, Bambino Gesù Children’s Hospital, IRCCS, 00146 Rome, Italy
1 shared publication - Arianna Maiorana
Division of Metabolic Diseases and Hepatology, Ospedale Pediatrico Bambino Gesù, Rome, Italy
1 shared publication - Ariel E. Feldstein
Department of Pediatric Gastroenterology, University of California, San Diego, San Diego, CA, United States
1 shared publication Fabrizio Gennari
Gastroenterology and Liver Unit, Bambino Gesù Children Hospital, Rome
1 shared publicationGiuliano Torre
Gastroenterology and Liver Unit, Bambino Gesù Children Hospital, Rome
1 shared publication- Jean de Ville de Goyet
Paediatric Liver Unit, ISMETT, Palermo, Italy
1 shared publication
Latest Publications
- 15 September 2010
- Published by Wiley in Pediatric Transplantation
- Vol. 15 (2) , E25-E29
Preemptive liver transplantation in a child with familial hypercholesterolemia
Familial hypercholesterolemia is an autosomal codominant disorder associated with markedly elevated plasma concentration of LDL-cholesterol and increased cardiovascular risk. Homozygous patients have rapid development of atherosclerosis with death from cardiovascular disease even in childhood. Life-long recurrent apheresis to reduce plasma LDL-cholesterol is considered the gold standard for treatment. Liver transplantation can be curative for this condition, but is usually only considered after the development of cardiovascular disease. We report a 5.5-yr-old child initially misdiagnosed with heterozygous familial hypercholesterolemia and treated by low-fat diet only. In view of persistent hypercholesterolemia and development of xanthomatosis, new molecular studies indicated the presence of two different mutations in the LDL receptor gene, with one being a deletion of two exons not identifiable with standard sequencing analysis. Recurrent plasma apheresis in combination with statins lowered, but did not normalize plasma LDL-cholesterol levels. It caused progressive reduction of the size of xanthomas and prevented the development of vascular complications. After two yr, liver transplantation normalized LDL-cholesterol levels and completely resolved the skin lesions. Preemptive liver transplantation is a definitive cure of familial homozygous hypercholesterolemia and might be more effective if performed before development of vascular complications.
- 15 September 2010
- Published by Wiley in Pediatric Transplantation
- Vol. 15 (2) , E25-E29
Preemptive liver transplantation in a child with familial hypercholesterolemia
Familial hypercholesterolemia is an autosomal codominant disorder associated with markedly elevated plasma concentration of LDL-cholesterol and increased cardiovascular risk. Homozygous patients have rapid development of atherosclerosis with death from cardiovascular disease even in childhood. Life-long recurrent apheresis to reduce plasma LDL-cholesterol is considered the gold standard for treatment. Liver transplantation can be curative for this condition, but is usually only considered after the development of cardiovascular disease. We report a 5.5-yr-old child initially misdiagnosed with heterozygous familial hypercholesterolemia and treated by low-fat diet only. In view of persistent hypercholesterolemia and development of xanthomatosis, new molecular studies indicated the presence of two different mutations in the LDL receptor gene, with one being a deletion of two exons not identifiable with standard sequencing analysis. Recurrent plasma apheresis in combination with statins lowered, but did not normalize plasma LDL-cholesterol levels. It caused progressive reduction of the size of xanthomas and prevented the development of vascular complications. After two yr, liver transplantation normalized LDL-cholesterol levels and completely resolved the skin lesions. Preemptive liver transplantation is a definitive cure of familial homozygous hypercholesterolemia and might be more effective if performed before development of vascular complications.
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5)
T1009 Severity of Liver Injury and Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5)
T1009 Severity of Liver Injury and Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease